SEC Filing Summary: AIKido Pharma Inc. (AIKI)
Business Context and Reporting Period
This Form 8-K was filed by AIKido Pharma Inc. on September 14, 2020. The filing addresses Item 5.08 regarding Shareholder Director Nominations and the scheduling of the 2020 Annual Meeting of Stockholders. The registrant is a Delaware corporation with its principal executive offices in New York, NY.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding corporate governance and meeting logistics, not a financial statement.
Material Changes
The primary material change disclosed is the rescheduling of the 2020 Annual Meeting of Stockholders. The meeting date has been set for November 17, 2020, which is a change of more than 30 days from the 2019 Annual Meeting. Consequently, the record date for determining stockholders entitled to vote is September 24, 2020.
Guidance, Outlook, and Corporate Actions
- Meeting Format: The 2020 Annual Meeting will be held virtually via live audio webcast.
- Nomination Deadline: Stockholders wishing to nominate a director or propose business must submit written notice to the Company Secretary by the close of business on October 1, 2020.
- Compliance Requirements: Nominations must meet SEC rules, including the submission of a Schedule 14N, to be eligible for inclusion in proxy materials.
- Voting Authority: If stockholders fail to comply with Rule 14a-4(c)(2), the Board may exercise discretionary voting authority on such proposals.
Key Facts for Investor Verification
- Verify the record date of September 24, 2020, to confirm eligibility to vote at the November 17, 2020, Annual Meeting.
- Confirm the October 1, 2020, deadline for submitting director nominations or stockholder proposals.
- Review the virtual meeting logistics and proxy materials once distributed to understand voting procedures.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.